Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 62.29B | 61.01B | 59.53B | 56.50B | 53.17B | 52.71B |
Gross Profit | 20.11B | 19.73B | 19.04B | 17.98B | 16.73B | 15.99B |
EBITDA | 7.25B | 6.90B | 6.64B | 6.17B | 5.79B | 4.96B |
Net Income | 2.47B | 2.17B | 2.10B | 1.92B | 1.88B | 1.11B |
Balance Sheet | ||||||
Total Assets | 40.45B | 40.88B | 38.98B | 38.15B | 36.61B | 35.87B |
Cash, Cash Equivalents and Short-Term Investments | 1.90B | 2.11B | 1.95B | 1.93B | 2.44B | 1.94B |
Total Debt | 19.52B | 19.18B | 18.17B | 17.61B | 16.55B | 16.61B |
Total Liabilities | 29.25B | 29.61B | 27.36B | 26.69B | 24.88B | 24.75B |
Stockholders Equity | 11.03B | 11.09B | 11.46B | 11.30B | 11.57B | 10.99B |
Cash Flow | ||||||
Free Cash Flow | 3.89B | 3.60B | 3.58B | 3.18B | 3.65B | 4.03B |
Operating Cash Flow | 5.86B | 5.80B | 5.65B | 4.75B | 4.83B | 5.19B |
Investing Cash Flow | -2.04B | -2.02B | -1.84B | -2.37B | -1.27B | -1.38B |
Financing Cash Flow | -4.15B | -3.82B | -3.93B | -2.75B | -3.25B | -3.28B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | C$13.05B | 19.17 | 13.02% | 1.45% | 1.77% | 0.77% | |
79 Outperform | $67.50B | 27.89 | 21.77% | 0.92% | 3.26% | 22.09% | |
70 Outperform | C$21.46B | 21.28 | 14.60% | 1.43% | 2.26% | 12.56% | |
70 Outperform | C$13.43B | 42.30 | -2.20% | 2.29% | 7.58% | -155.93% | |
67 Neutral | C$2.34B | 17.00 | 18.85% | 3.28% | 4.19% | 2.56% | |
67 Neutral | C$33.97B | 33.73 | 17.72% | 1.28% | 3.21% | -12.20% | |
53 Neutral | C$5.40B | 6.74 | 11.95% | 3.33% | 4.99% | -1.01% |
Loblaw Companies Limited announced a four-for-one stock split of its common shares, effective August 18, 2025, to enhance accessibility for retail investors and employees, and improve share liquidity. This strategic move is designed to maintain shareholder equity without incurring Canadian income tax liabilities, reflecting Loblaw’s commitment to its stakeholders and market positioning.
The most recent analyst rating on (TSE:L) stock is a Buy with a C$189.00 price target. To see the full list of analyst forecasts on Loblaw Companies stock, see the TSE:L Stock Forecast page.
Loblaw Companies reported a 5.2% revenue growth in the second quarter of 2025, driven by increased customer traffic, larger basket sizes, and higher unit sales. The company saw strong performance in both its food and drug retail segments, with notable growth in pharmacy and healthcare services. Loblaw’s expansion strategy includes opening new stores and pharmacy clinics across Canada, enhancing its market presence. Additionally, the company announced a 4-for-1 stock split to maintain share accessibility for retail investors and employees, reflecting confidence in its growth trajectory.
The most recent analyst rating on (TSE:L) stock is a Buy with a C$189.00 price target. To see the full list of analyst forecasts on Loblaw Companies stock, see the TSE:L Stock Forecast page.